Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07464353) titled 'xDot Access Management System Early Feasibility Study' on March 6.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: xDot Medical, Inc

Condition: Vascular Closure Devices

Intervention: Device: xDot Access Management System (AMS)

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: April 2026

Target Sample Size: 30

To know more, visit https://clinicaltrials.gov/study/NCT07464353

Published by HT Digital Content Services with permission from Health Daily Digest...